MS Study Evaluating Safety and Efficacy of Two Doses of Fingolimod Versus Copaxone

Condition:   Relapsing-remitting Multiple Sclerosis (RRMS)Interventions:   Drug: fingolimod;   Drug: copaxoneSponsor:   Novartis PharmaceuticalsRecruiting - verified December 2014

Source: ClinicalTrials.gov - June 29, 2012 Category: Research Source Type: clinical trials